Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

NICE approves Roche’s Tecentriq in TNBC after revising deal

NICE approves Roche’s Tecentriq in TNBC after revising deal

Discounted price deal sees immunotherapy recommended for use. The UK’s National Institute for Health and Care Excellence (NICE) has recommended Roche’s immunotherapy Tecentriq for patients with triple-negative breast ... NICE has now recommended

Latest news

More from news
Approximately 390 fully matching, plus 823 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 117 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 47 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics